Collegium Pharmaceutical Inc (COLL)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,663,590 | 234,279 | 216,583 | 222,169 | 195,431 | 178,873 | 200,805 | 179,733 | 194,842 | 197,194 | 197,612 | 196,076 | 202,928 | 251,094 | 253,066 | 170,035 | 186,031 | 172,686 | 155,767 | 141,063 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,663,590K
= 0.00
The debt-to-equity ratio for Collegium Pharmaceutical Inc has consistently remained at 0.00 from March 2020 to December 2024. This indicates that the company has not utilized debt as a source of financing in relation to its equity during this period. A debt-to-equity ratio of 0.00 signifies that the company's total liabilities are either minimal or non-existent in comparison to its equity, suggesting a conservative financial structure with a lower financial risk. It is important to consider other financial metrics and factors in conjunction with the debt-to-equity ratio to gain a comprehensive understanding of Collegium Pharmaceutical Inc's overall financial health and performance.
Peer comparison
Dec 31, 2024